PWA
CRL icon

Physician Wealth Advisors’s Charles River Laboratories CRL Stock Holding History

Physician Wealth Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.75K Buy
43
+13
+43% +$2.31K ﹤0.01% 883
2026
Q1 		$5.17K Hold
30
– – ﹤0.01% 994
2025
Q4 		$5.99K Hold
30
– – ﹤0.01% 920
2025
Q3 		$4.69K Buy
30
+3
+11% +$476 ﹤0.01% 939
2025
Q2 		$4.1K Buy
27
+23
+575% +$3.07K ﹤0.01% 849
2025
Q1 		$603 Buy
+4
New +$671 ﹤0.01% 1339

Other funds holding CRL

CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
CPCPP
Canada Post Corporation Pension Plan Toronto, Canada $2.87B AUM 37.96% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
CCMINC
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Physician Wealth Advisors's CRL Position: Q2 2026 in Review

Physician Wealth Advisors increased its Charles River Laboratories (CRL) stake by 43% in Q2 2026, buying an estimated $2.31K and bringing the position to 43 shares worth $9.75K. The position accounts for ﹤0.01% of the portfolio, ranked #883.

Physician Wealth Advisors first reported a position in CRL in Q1 2025 and has held it in 6 quarters since. 85 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Physician Wealth Advisors held 43 shares of Charles River Laboratories worth $9.75K as of Q2 2026.
  • Physician Wealth Advisors bought 13 Charles River Laboratories shares in Q2 2026, an estimated $2.31K.
  • Charles River Laboratories made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #883 holding.
  • Physician Wealth Advisors first reported a position in Charles River Laboratories in Q1 2025 and has held it in 6 quarters since.
  • 85 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.